The Arora Report

Rss Facebook Twitter Linkedin

MYGN

NEW IDEA ON MYRIAD GENETICS, THE INVENTOR OF BREAST CANCER GENETIC TEST $MYGN $LH $DGX

This post was just published on ZYX Short Change Alert. MYGN’s claim to fame is a test to identify BRCA mutations that increase the risk of breast and ovarian cancers.  Previously, DGX announced plans to compete with MYGN. Today LH announced the nationwide availability of a suite of tests to identify

Read More
December 2, 2013

9 Winners. 9 Losers. Gold, Silver & AI Trade Zones.

9 Winners. 9 Losers.
Gold, Silver & AI Trade Zones.

A new market cycle is forming.

AI, Metals &
Memory Playbook

See where sophisticated investors are positioning across software, precious metals, and AI memory.

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

Skip to content